Nuvio Pharmacy Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -3.49%
- Profit Growth 176.85%
- Ebitda 176.85%
- Net Worth 10.60%
- Total Assets -37.16%
About Nuvio Pharmacy
Nuvio Pharmacy Private Limited (NPPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 October 2020 (Four years and four months 3 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Saif Ali and Prasuna Pannati serve as directors at the Company.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24110MH2020PTC347485
-
Company No.
347485
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
08 Oct 2020
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Nuvio Pharmacy?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prasuna Pannati
|
Managing Director | 08-Oct-2020 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Saif Ali
|
Director | 08-Oct-2020 | Current |
Financial Performance of Nuvio Pharmacy.
Nuvio Pharmacy Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 3.49% decrease. The company also saw a substantial improvement in profitability, with a 176.85% increase in profit. The company's net worth Soared by an impressive increase of 10.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nuvio Pharmacy?
Unlock access to Nuvio Pharmacy's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Nuvio Sellers Private LimitedSaif Ali and Prasuna Pannati are mutual person
-
Nuvio Technologies Private Limited
Prasuna Pannati is a mutual person
-
Aeroxe Enterprises Private LimitedSaif Ali is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nuvio Pharmacy?
Nuvio Pharmacy has a workforce of 0 employees as of Oct 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nuvio Pharmacy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nuvio Pharmacy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.